Profile
Kirsten Harting currently works at SynAct Pharma AB, as Chief Medical Officer from 2024 and Tetra Pharm Technologies ApS, as Chief Medical Officer.
Dr. Harting also formerly worked at CytoKi Pharma ApS, as Senior Director-Medical, Alzinova AB, as Chief Medical Officer from 2023 to 2025, and Sandoz Group AG, as Chief Medical Officer.
Dr. Harting received her Masters Business Admin degree from Copenhagen Business School and doctorate degree from the University of Copenhagen.
Kirsten Harting active positions
| Companies | Position | Start |
|---|---|---|
| SYNACT PHARMA AB | Chief Tech/Sci/R&D Officer | 15/02/2024 |
Tetra Pharm Technologies ApS
Tetra Pharm Technologies ApS Pharmaceuticals: MajorHealth Technology Engages in the design and development of new drug formulations, conduct clinical trials and commercialize medicines | Chief Tech/Sci/R&D Officer | - |
Former positions of Kirsten Harting
| Companies | Position | End |
|---|---|---|
| ALZINOVA AB | Chief Tech/Sci/R&D Officer | 28/01/2025 |
| SANDOZ GROUP AG | Chief Tech/Sci/R&D Officer | - |
CytoKi Pharma ApS
CytoKi Pharma ApS Miscellaneous Commercial ServicesCommercial Services Provides biotechnological research and development services | Chief Tech/Sci/R&D Officer | - |
Training of Kirsten Harting
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Copenhagen Business School
Copenhagen Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Copenhagen
University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alzinova AB
Alzinova AB Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provides treatment for Alzheimer’s disease | Health Technology |
SynAct Pharma AB
SynAct Pharma AB Pharmaceuticals: MajorHealth Technology Provides pharmaceutical drugs for treatment inflammatory diseases | Health Technology |
CytoKi Pharma ApS
CytoKi Pharma ApS Miscellaneous Commercial ServicesCommercial Services Provides biotechnological research and development services | Commercial Services |
Tetra Pharm Technologies ApS
Tetra Pharm Technologies ApS Pharmaceuticals: MajorHealth Technology Engages in the design and development of new drug formulations, conduct clinical trials and commercialize medicines | Health Technology |
Sandoz Group AG
Sandoz Group AG Pharmaceuticals: MajorHealth Technology Manufactures medicines and biosimilars | Health Technology |
- Stock Market
- Insiders
- Kirsten Harting
















